BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11081203)

  • 1. Morphological characterization and subtyping of silent somatotroph adenomas.
    Naritaka H; Kameya T; Sato Y; Furuhata S; Otani M; Kawase T
    Pituitary; 1999 May; 1(3-4):233-41. PubMed ID: 11081203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine and morphological study of a clinically silent somatotroph adenoma of the human pituitary.
    Yamada S; Sano T; Stefaneanu L; Kovacs K; Aiba T; Sawano S; Shishiba Y
    J Clin Endocrinol Metab; 1993 Feb; 76(2):352-6. PubMed ID: 8432778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone (GH) and prolactin (PRL) gene expression and immunoreactivity in GH- and PRL-producing human pituitary adenomas.
    Li J; Stefaneanu L; Kovacs K; Horvath E; Smyth HS
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(3):193-201. PubMed ID: 8493775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological analyses of silent pituitary somatotroph adenomas using immunohistochemistry, in situ hybridization and confocal laser scanning microscopic observation.
    Matsuno A; Itoh J; Itoh Y; Osamura RY; Katayama H; Nagashima T
    Pathol Res Pract; 2001; 197(1):13-20. PubMed ID: 11209812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and functional properties of densely and sparsely granulated GH-producing pituitary adenomas.
    Mayr B; Buslei R; Theodoropoulou M; Stalla GK; Buchfelder M; Schöfl C
    Eur J Endocrinol; 2013 Oct; 169(4):391-400. PubMed ID: 23847328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary adenomas that show a faint GH-immunoreactivity but lack fibrous body: Pit-1 adenoma with endocrinologically low activity.
    Yoneda A; Sano T; Yamada S; Obari A; Qian ZR; Wang EL; Inosita N; Kudo E
    Endocr Pathol; 2010 Mar; 21(1):40-7. PubMed ID: 20111911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinicomorphological study of pituitary tumors associated with the clinical syndrome of acromegaly.
    Andreeva M; Georgiev T; Bosadjieva E; Karagiosov L; Karagiosov K; Tomova A; Matrosov P; Kirilov G; Diankov L; Christova T
    Exp Clin Endocrinol; 1991; 98(3):223-7. PubMed ID: 1778242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone and prolactin gene expression in human densely and sparsely granulated somatotroph adenomas by in situ hybridization with digoxigenin-labeled probes.
    Yamada S; Takahashi M; Hara M; Sano T; Aiba T; Shishiba Y; Suzuki T; Asa SL
    Diagn Mol Pathol; 1994 Mar; 3(1):46-52. PubMed ID: 8162255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone-producing pituitary adenomas: correlations between clinical characteristics and morphology.
    Yamada S; Aiba T; Sano T; Kovacs K; Shishiba Y; Sawano S; Takada K
    Neurosurgery; 1993 Jul; 33(1):20-7. PubMed ID: 7689191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of alpha-subunit of glycoprotein hormones by pituitary somatotroph adenomas in vitro.
    Kontogeorgos G; Asa SL; Kovacs K; Smyth HS; Singer W
    Acta Endocrinol (Copenh); 1993 Dec; 129(6):565-72. PubMed ID: 7509101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the growth-hormone-releasing hormone gene in acromegaly-associated pituitary tumors. An event associated with neoplastic progression and aggressive behavior.
    Thapar K; Kovacs K; Stefaneanu L; Scheithauer B; Killinger DW; Lioyd RV; Smyth HS; Barr A; Thorner MO; Gaylinn B; Laws ER
    Am J Pathol; 1997 Sep; 151(3):769-84. PubMed ID: 9284826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone-releasing hormone expression in pituitary somatotroph adenomas, studied by immunohistochemistry and in situ hybridization using catalyzed signal amplification system.
    Matsuno A; Katakami H; Nagashima T; Teramoto A; Osamura RY; Kirino T
    Hum Pathol; 2000 Jul; 31(7):789-94. PubMed ID: 10923914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Silent' somatotropinoma.
    Pawlikowski M; Kuta J; Fuss-Chmielewska J; Winczyk K
    Endokrynol Pol; 2012; 63(2):88-91. PubMed ID: 22538745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A growth hormone-releasing hormone-producing pancreatic islet cell tumor metastasized to the pituitary is associated with pituitary somatotroph hyperplasia and acromegaly.
    Sanno N; Teramoto A; Osamura RY; Genka S; Katakami H; Jin L; Lloyd RV; Kovacs K
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2731-7. PubMed ID: 9253362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of growth hormone-releasing hormone (GHRH) on densely granulated somatotroph adenomas and sparsely granulated somatotroph adenomas in vitro: a morphological and functional investigation.
    Kawakita S; Asa SL; Kovacs K
    J Endocrinol Invest; 1989; 12(7):443-48. PubMed ID: 2551950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form.
    Obari A; Sano T; Ohyama K; Kudo E; Qian ZR; Yoneda A; Rayhan N; Mustafizur Rahman M; Yamada S
    Endocr Pathol; 2008; 19(2):82-91. PubMed ID: 18629656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture.
    Matsuno A; Sasaki T; Mochizuki T; Fujimaki T; Sanno N; Osamura Y; Teramoto A; Kirino T
    Acta Neurochir (Wien); 1996; 138(8):1002-7. PubMed ID: 8890999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin receptor subtype gene expression in pituitary adenomas.
    Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function correlations of growth hormone or/and prolactin-producing pituitary adenomas: an in vitro study with the reverse hemolytic plaque assay.
    Thodou E; Kontogeorgos G; Kyrodimou E; Salla H; Ramyar L; Vamvassakis E; Piaditis G; Anagnostopoulos N; Tzanis S; Levedis A; Rologis D; Asa SL
    J Endocrinol Invest; 1999 Oct; 22(9):671-80. PubMed ID: 10595830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.
    Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T
    Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.